Medtronic Stock Forecast for 2023 - 2025 - 2030
Updated on 04/18/2024
Medtronic Stock Forecast and Price Target
The average price target of $95.50 for Medtronic's stock set by Twenty one distinguished analysts in recent weeks would represent a potential upside of approximately 20.6% from the last closing price in April, 2024 if reached by the end of the year. This potential increase is based on a high estimate of $112.00 and a low estimate of $75.00. If you're thinking of investing in MDT stock, it might be good to look at its rivals too.
20.60% Upside
Medtronic Fair Value Forecast for 2023 - 2025 - 2030
In the last three years, Medtronic's Price has seen an increase, rising from $87.44 to $100.77. This represents a growth of 15.25%. Analysts predict that Medtronic's Fair Value will increase in the upcoming year, reaching $121.16. This would represent an increase of 20.23%. Over the next seven years, experts predict that Medtronic's Fair Value will grow at a rate of 48.46%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ABBV Stock Forecast | AbbVie | Outperform |
9
|
$164.66 | Buy/Sell | $178.42 | 14.78% |
| AZN Stock Forecast | AstraZeneca PLC | Outperform |
17
|
£109.14 | Buy/Sell | £165.99 | 48.27% |
| ABT Stock Forecast | Abbott Laboratories | Outperform |
9
|
$105.27 | Buy/Sell | $118.92 | 20.64% |
| GE Stock Forecast | General Electric | Outperform |
8
|
$152.94 | Buy/Sell | $144.00 | 10.17% |
| AMGN Stock Forecast | Amgen | Outperform |
4
|
$262.75 | Buy/Sell | $303.65 | 20.74% |
Medtronic Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Medtronic's Revenue has seen an increase, rising from $28.91B to $31.23B. This represents a growth of 8.00%. Analysts predict that Medtronic's Revenue will increase in the upcoming year, reaching $35.12B. This would represent an increase of 12.45%. Over the next seven years, experts predict that Medtronic's Revenue will grow at a rate of 39.78%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BSX Stock Forecast | Boston Scientific | Outperform |
11
|
$67.42 | Buy/Sell | $70.14 | 8.28% |
| BMY Stock Forecast | Bristol-Myers Squibb | Hold |
2
|
$48.30 | Buy/Sell | $58.15 | 13.87% |
| CVS Stock Forecast | CVS Health | Outperform |
12
|
$69.39 | Buy/Sell | $89.54 | 26.82% |
.jpg)
Medtronic Dividend per Share Forecast for 2023 - 2025 - 2030
Medtronic's Dividend per Share has seen growth In the last three years, going from $2.16 to $2.72 – a gain of 25.93% In the next year, analysts believe that Dividend per Share will reach $2.88 – an increase of 5.88%. For the next seven years, the forecast is forDividend per Share to grow by 22.77%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GILD Stock Forecast | Gilead Sciences Inc | Outperform |
11
|
$66.16 | Buy/Sell | $87.82 | 23.94% |
| GSK Stock Forecast | GSK | Outperform |
12
|
£15.84 | Buy/Sell | £17.30 | 23.11% |
| BDX Stock Forecast | Becton Dickinson and Co | Outperform |
9
|
$233.15 | Buy/Sell | $284.47 | 20.09% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| EW Stock Forecast | Edwards Lifesciences Corp | Outperform |
11
|
$86.45 | Buy/Sell | $91.18 | 12.20% |
| DXCM Stock Forecast | DexCom Inc | Buy |
12
|
$134.30 | Buy/Sell | $125.98 | 11.69% |
| MMM Stock Forecast | 3M | Hold |
10
|
$91.48 | Buy/Sell | $109.39 | 9.31% |
Medtronic EBITDA Forecast for 2023 - 2025 - 2030
Medtronic's EBITDA has grown in the last three years, jumping from $7.83B to $8.12B – an increase of 3.81%. In the next year, analysts predict that EBITDA will reach $11.05B – an increase of 36.00%. For the next seven years, the forecast is for EBITDA to grow by 49.84%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ALC Stock Forecast | Alcon | Outperform |
8
|
CHF72.12 | Buy/Sell | CHF90.64 | 33.61% |
| BIIB Stock Forecast | Biogen | Outperform |
10
|
$190.52 | Buy/Sell | $299.62 | 53.26% |
| 4901 Stock Forecast | FUJIFILM Holdings | Buy |
18
|
¥9.41k | Buy/Sell | ¥10.57k | 9.43% |
Medtronic EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Medtronic's EBIT has increased by 10.02%, going from $5.16B to $5.68B. In the next year, analysts are expecting an increase in EBIT, predicting it will reach $10.06B – an increase of 77.22%. The Medtronic forecast is for EBIT to reach $14.32B or grow by 152.09%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 7751 Stock Forecast | Canon | Hold |
18
|
¥4.28k | Buy/Sell | ¥3.74k | -11.24% |
| BAX Stock Forecast | Baxter International Inc | Outperform |
17
|
$39.65 | Buy/Sell | $44.86 | 13.49% |
| ABMD Stock Forecast | Abiomed | - |
16
|
$377.79 | Buy/Sell | $380.00 | -88.33% |
Medtronic EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last three years, Medtronic's EPS has seen an increase, rising from $4.59 to $5.29. This represents a growth of 15.25%. Analysts predict that Medtronic's EPS will increase in the upcoming year, reaching $6.36. This would represent an increase of 20.23%. Over the next seven years, experts predict that Medtronic's EPS will grow at a rate of 48.46%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| FME Stock Forecast | Fresenius Medical Care AG & Co... | Hold |
18
|
36.43€ | Buy/Sell | 41.13€ | 5.68% |
| CYTK Stock Forecast | Cytokinetics | Outperform |
10
|
$67.00 | Buy/Sell | $87.92 | 40.30% |
| GMED Stock Forecast | Globus Medical | Outperform |
16
|
$50.75 | Buy/Sell | $64.58 | 18.23% |
.jpg)